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The incidence and epidemiology of bacteraemia has been widely 
1-13 
reported in the United States and Europe but little data is 
available from Southern Africa. In addition, most studies have 
concentrated on the overall incidence of 




and it is 
difficult to interpret the data from these studies with regard to 
co!lllllunity acquired bacteraemia. From a retospective survey of 
summaries from a single medical ward at Groote Schuur Hospital 
it was estimated that bacteraemia accounted for about 47. of the 
total admissions. It was therefore thought useful to provide 
clinicians particularly at Groote Schuur Hospital with 
information about community acquired bacteraemia to improve 
overall patient management. With this in mind it was d~cided to 
undertake a comprehensive prospective study of collllllunity acquired 
bacteraemia at Groote Schuur Hospital. 
PATIENTS AND METHODS 
Between 1st February 1986 and 31st January 1987 all positive 
blood cultures from the Groote Schuur Hospital Bacteriology 
Laboratory were reported to the investigators (Dr. Paul Willcox 
and myself) and were analysed prospectively to determine the 
incidence, patient profile and outcome of community acquired 
bacteraemia. 
1> BLOOD CULTURE TECHNIQUE 
3 - 5 mls of blood was innoculated into a 70 anaerobic and 68 
aerobic BACTEC blood culture bottles (Johnson Laboratories) 
2 
respectively. Each contained 30 mls of volume enriched tryptic 
14 
soy broth, anticoagulant and C labelled substrate. Aerobic 6B 
bottles were incubated at 37°C and te~ted on the BACTEC 460 twice 
on the first day and once daily for 7 days.Anaerobic 7D bottles 
were incubated at 37 C and tested daily from days 2 - 7. A growth 
index of 35 or more and 20 or more for aerobic and anaerobic 
bottles respectively was considered positive. A gram stained 
slide was then prepared on positive bottles and appropriate 
identification and antibiotic sensitivity testing performed. 
2) DEFINITIONS 
Cl) ColDJllunity acquired bacteraemia 
An episode of bacteraemia was considered to be community acquired 
if the culture was obtained within 48 hours of admission unless 
it was related to a procedure after admission or it was 
considered a contaminant. Other exclusion criteria were that the 
patient was 12 year~ or younger since most paediatric cases are 
admitted elsewhere; had an indwelling catheter; and was involved 
in trauma prior to admission. 
<2> Statistical analysis 
2 
All statistical testing was done by X test, 
or student "t" test. 
(3) Outcome 
Fisher's exact test 
This was only analysed during the hospital stay and patients 
dying after discharge were considered to have survived for 
purposes of the study. 
3 
EPIDEHIOLOGY 
RESULTS. During the study period blood cultures were taken from 
4595 patients and a positive growth was obtained in 626. Two 
hundred and thirty nine of these were considered to have 
community acquired bacteraemia. The remaining 387 patients had 
either hospital acquired bacteraemia or contamination of the 
blood culture.In the same period 53,208 patients were admitted to 
Groote Schuur Hospital and the overall prevalence of community 
acquired bacteraemia was 4.5/1000 admissions. 
DISCUSSION. The prevalence of community acquired bacteraemia 
appears to be low but many admissions to hospital are for 
elective surgical procedure~, trauma or inpatient investigation 
and it is difficult to determine the exact prevalence in relation 
to acute hospital admissions. However it probably can be inferred 
that it is a important problem in emergency medicine. 
Interestingly the prevalence of 4.5/1000 admissions closely 
correlates with the community acquired data of a 




RESULTS. Of the 239 episodes 117 occured in females and 122 in 
males with a mean age of 48 years (range 13 - 90). There were 
142 mixed race, 52 white, 44 black and 1 Asian patient. The 
overall mortality was 29.27. <70 patients). There was no 
statistical difference in mortality in relation to sex or race of 
the patients. Figure 1 shows the relationship of mortality to 
age. Mortality was significantly higher in patients> 30 years 
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FIG. 1. Mortality related to age of patient.. 
DISCUSSION. The overall mortality for the study was 29.27. which 
is considerable. This figure is comparable to earlier studies and 
despite the development of newer and more powerful antibiotics 
and modern intensive care support mortality is high. Later in 
depth discussion of particular aspects of the study will try and 
elucidate the reasons for this. 
Surprisingly mortality rose sharply after the age of 30 years 
and remained relatively constant. (Figure 1) There was no 
significant difference in outcome between the under and over 65's 
in a recent survey (0. Whitelaw personal communication} This is 
an important clinical observation as it is not Just elderly 
patients who are at high risk. 
ORGANISKS 
1 > OVERALL. 
RESULTS. The distribution of organisms and their relationship to 
mortality is shown in Table 1. There were 108 episodes of gram 
negative bacteraemia and 131 gram positive with very similar 
mortalities (26.8 versus 29.57.,NS}. Tfte most common isolate was 
5 
Escherichia coli CE.Coli> followed by Streptoccu.s pneumoniae cs. 
pneumoniae) and .Staphylococcus aureus cs. aureus). Mortality was 
highest in the haemolytic .streptococci (72. 7"1. p<0,003) and 
Klebsiella gt~oup C61Z p<0,005 ) . The lowest mortality was 
recorded in the Viridans ~treptoccal group (OZ p<0,02) and E.coli 
(18.87. p(0,04 ). Polymicrobial bacteraeaia accounted for ten 
episodes with only a 201. mortality. (N.S.> 
TABLE 1 INFECTING ORGANISMS AND MORTALITY 
EPISODES 1. DEATHS 1. 
GRAN NEGATIVE 
E. coli 69 28.9 13 18.8 p<0,04 
Klebsiella sp. 18 7.5 11 61. 1 p<0,005 
Salaonella typhi 4 1.6 0 0 
N. meningitides 4 1.6 0 0 
ff.Influenza 3 1.2 1 33.3 
Salaonella sp. 2 0.8 1 50 
Pseudomonas sp. 2 0.8 2 100 
Miscellaneous 6 2.5 1 16.6 
TOTAL 108 45 29 26.8 
GRAN POSITIVES 
S.pneuaoniae 51 21. 3 17 33.3 
s. aureus 29 12. 1 12 41.3 
Viridans Strepto- 14 5.8 0 0 p=0,02 
cocci 
Haeaolytic Strepto- 11 4.6 8 72.7 p<0,003 
cocci <A,B,& C) 
Peptococcus 5 2 0 0 
Miscellaneous 11 4.6 2 14.2 
TOTAL 121 50.6 39 29.5 
POLYMICROBIAL 10 4.2 2 20 
GRAND TOTAL 239 100 70 29.2 
DISCUSSION. The most common organisms found in the study were E. 
coli, Klebsiella sp, S. pneumoniae and S. aureus which is what 
6 
1,2,6,7,9,10,12 
has been described from other centres. H. 
influenzae was not a common isolate due to the exclusion of 
paediatric patients from our gtudy. .Opportunistic organisms had 
a low incidence. Analysis of mortality data showed no difference 
between gram negative and positive organisms or polyaicroblal 
1,3 
infection unlike other series. Although gram negative sepsis 
has historically a worse outcome it would appear that better 
management has contributed to the decline in mortality. Two 
specific organisas were associated with a particularly high 
mortality, namely the Klebslella and haeaolytic streptoccal group 
which contrasted with the low rates for the E. coli and S. 
vlridans group. The clinical features and outcome of the 
common and important organisms in the study will be dicussed in 
detail below. 
2> E.COLI 
RESULTS. E. coll was thP. most coaaon organism in the study 
occurring in 69 patients (297.). 
group are shown in table 2. 
7 
The clinical features of this 
TABLE 2. CLINICAL FEATURES OF E. COLI. BACTERAEMIA. 
EPISODES 7. DEATHS 7. 
NUMBER 69 29 13 19 
SEX 
Males 18 26 5 28 
Females 51 74 8 16 
SITE 
Urinary tract 46 67 6 13 
Undetermined 15 22 5 33 
Biliary 5 7 0 0 
UNDERLYING DISEASE 
Diabetes 28 41 8 29 
Nil 9 13 1 11 
Malignancy 7 10 
COMPLICATIONS 
Acute renal failure 18 26 5 28 
espiratory failure 6 9 3 50 
Hepatic dysfunction 9 13 
D. I. C. 4 6 
Shock 7 10 2 29 
C USE OF DEATH 
Bacteraem.ia 10 77 
Nosocom.ial sepsis 1 8 
Miscellaneous 2 15 
DISCUSSION. E. coli is a normal commensal of the gastro-
intestinal tract. It is responsible for over 907. of community 
acquired urinary tract infections (UTirs) and a common pathogen 
20 
in gastro-intestinal and biliary infection. It is therefore not 
surprising that the most common source of infection was the 
urinary system in 46 patients {677.) and the major predisposing 
factors are the female sex and diabetes mellitus in 747. and 417. 
of cases respectively. Fifteen patients had no primary site 
identified but in many of these cases mid-stream urines were not 
sent for culture prior to starting antibiotics. 
Interestingly the mortality for th~ group was significantly 
8 
lower compared to the rest of the bacteraeaic patients 197. 
versus 347., p <0.04} which is rather surprising for a serious 
gram negative bacteraeaia. This may be because bacteraeaia 
arising from the urinary tract represents a less serious invasion 
of the body defence mechanism.s compared to infection arising from 
the lungs (see Klebsiella and S. aureus infection} or E. coli is 
inherently less virulent. 
The most common coaplication was acute renal failure <ARF> 
probably due to a combination of pyelonephritis and bacteraeaia. 
Other major complications of bacteraeaia shock and respiratory 
failure had a relatively low incidence and in an addition a low 
aortality compared with other bacteraeaias. 
3} KLEBSIELLA 
RESULTS. Klebsiella bacteraeaia accounted for only 18 episodes 
of bacteraeaia but nevertheless foraed an important subgroup of 
patients. The clinical features are shown in table 3. 
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TABLE 3. CLINICAL FEATURES OF KLEBSIELLA BACTERAE.l"IIA. 
EPISODES 7. DEATHS 7. 
NU.l"IBER 18 7. 5 · 11 61 
SEX 
Females 3 17 1 33 
Hales 15 83 10 67 
SITE 
Respirat.ory 10 56 8 80 
Urinary t.ract. 6 33 1 17 
1'1i.scellaneou.s 2 11 2 100 
UNDERLYING DISEASE 
Diabet.es 5 28 2 40 
Kalignancy 2 11 1 50 
Nil 6 33 5 83 
CO.l"IPLICATIONS 
Acute renal failure 8 44 5 63 
Respiratory failure 11 61 7 64 
Hepatic dysfunction 4 22 
D. I. C. 4 22 
Shock 6 28 6 100 
CAUSE OF DEATH 
Bact.eraeaia 10 91 
Miscellaneous 1 9 
DISCUSSION. Klebsiella infection is an i .mportant cause of 
nosocomial sepsis, and a less common cause of community acquired 
20 
pneumonia and urinary t.ract infection. In this survey the 
aortality of Klebsiella bacteraemia was significantly higher than 
the rest of the group (617. versus 277., p<0.005). The majority of 
deaths occured if the primary site of infection was the lungs 
compared to a negligible mortality if this was the urinary tract 
(807. versus 177. respectively). 
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A similar observation was made by 
I1ontgomerie. The reason for the difference in mortality was 
probably due to the high incidence of chronic alcoholism in the 
former group suggesting that aspiration may have been the 
precipitating event. These patients were all extremely ill often 
requiring urgent admission to an intensive care unit for 
respiratory support. None of the patients received combination 
10 
antibiotics Ca cephalosporin and an aminoglycoside} 
This regimen has been recommended for serious 
20 
infection and may have helped reduce mortality. 
initially. 
Klebsiella 
Because of the very poor outcome of Klebsiella pneumonla it is 
extremely important that clinicians recognise this condition 
before cultures are available so that aggressive, early and 
appropriate treatment can be instituted. It should be suspected 
in any male alcoholic with pneumonia particularly if complicated 
by respiratory failure. 
3). S. PNEUMONIAE. 
RESULTS. Pneumococcal bacteraemia formed the second most common 
isolate in the survey. The clinical features are shown on Table 4. 
"" BLE 4. CLINICAL FEATURES OF s. PNEUMOMONIAE BACTERAEMIA. 
EPISODES 7. DEATHS '1. 
NUMBER 51 21 17 33 
SEX 
Hale 32 63 9 28 
Female 19 37 8 42 
ALCOHOLISM 14 27 7 50 
SITE 
Respiratory 43 84 14 33 
Undetermined 3 6 1 33 
Miscellaneous 5 10 2 40 
UNDERLYING DISEASE 
Nil 20 39 3 15 
Diabetes 5 10 2 40 
Chronic lung disease 8 16 5 63 
COMPLICATIONS 
Acute renal failure 12 24 7 58 
Respiratory failure 8 16 6 75 
Hepatic dysfunction 5 10 
D. J.C. 2 4 
Shock 8 16 7 88 
CAUSE OF DEATH 
Bacteraemia 10 59 
Pulmonary embolus 2 12 
.Kisc.ellaneous 5 29 
11 
DISCUSSION. s. pneumoniae is the most coaaon form of coaaunity 
acquired bacterial pneumonia and is coaplicated by bacteraemia in 
1/3 of cases. Mortality depends on the serotype involved and can 
range from 10 - 507.. No serotype analysis was done in our 
patients. Mortality in this survey was 33 Y. which is extremely 
high and leaves no room for coaplacency in the treataent of this 
disorder. Patients with the worst outcome usually had underlying 
chronic lung disease or alcohol abuse (637. and 507. aortality 
respectively) although the numbers are small to draw definitive 
conclusions. 
Interestingly not all deaths were due to bacteraeaia. In 3 
patients the cause of death was not established and 2 died of 
pulaonary eaboli. It is uncertain if the death rate for 
pneumococcal bacteraemia can be reduced as most patients were 
treated appropriately. Even admJssion to the intensive care seems 
23 
to have limited impact on mortality. 
4) VJRIDANS STRl!:PTOCOCCAL BACTERAEMIA. 
D~FINITION. This group included Streptococcus mitior, salivarius, 
and sangui.!3. 
RESULTS. This organism accounted for a small number of cases in 
this survey but was iaportant because of its significantly 
reduced mortality. (0/14, 
shown in table 5. 
p(0.02 
12 
). The clinical features are 
TABLE 5. CLINICAL FEATURES OF s. VIRIDANS BACTERAEHIA. 
EPISODES 7. DEATHS 7. 
NUl'1BER 14 6 0 0 
SEX 
Hale 7 50 
Female 7 50 
ALCOHOLISM 4 29 
SITE 
Cardiac 6 43 
Undetermined 4 29 
Miscellaneous 4 29 
UNDERLYING DISEASE 
Nil 3 21 
Diabetes 1 7 
Cardiac 6 43 
COl'1PLICATIONS 
Acute renal failure 0 0 
Respiratory failure 0 0 
Hepatic dysfunction 1 7 
D. LC. 0 0 
Shock 0 0 
DCSCUSSION. This group of organislll.9 are usually normal coaaensals 
of the oropharynx but cause significant aorbidity due to dental 
caries and local sepsis. Transient bacteraemias aay follow dental 
manipulation and endocarditis may occur in susceptible 
individual s wlth underlying valvular or congenital heart disease. 
This is well borne out by the survey as 6 patients (437.) had 
underlying endocarditis complicating rheuaatic or congenital 
heart di s ease. No relationship could be found to previous dental 
work . The source of infection was unknown in 4 cases. 
Despite a high incidence of endocarditis in this group the 
mortality was zero suggesting that this organism is not 
virulent and / or extreaely susceptible to particularly 
antibiotics. This is also readily apparent by the complete 
absence of complications s ave 1 case of jaundice. 
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5) HAEHOLY"FIC STREPTOCOCCI GROUP A,B,C,E. 
RESULTS. This was a small but important group because of a 
significantly increa~ed mortality. 
features are shown in table 6. 
{73%, p<0.003) The clinical 
TABLE 6. CLINICAL FEATURES OF ~ HAEMOLYTIC STREPTOCOCCAL 
BACTERAEl'IIA. 
EPISODES 7. DEATH 'l. 
NUl'IBER 11 5 8 73 
SEX 
l'lale 4 36 2 50 
Feaale 7 64 6 86 
SITE 
Skin 6 55 5 83 
Undeterained 4 36 3 75 
Hi sc'e 11 aneous 1 9 
UNDERLYING DISEASE 
Nil 1 9 
Diabetes 5 45 4 80 
Cancer 4 36 3 75 
COHPLICATIONS 
Acute renal failure 4 36 4 100 
Respiratory failure 2 18 2 100 
Endocarditis 2 18 2 100 
Shoc-k 2 18 2 100 
CAUSE OF DEATH 
Bacteraeaia 6 55 
Cancer 1 18 
Hiscellaneous 1 9 
DISCUS.SION. Group A B haemolytic streptococci are common 
pathogens in man causing tonsillitis and skin infection. Other 
groups can cause gynaecological sepsis and neonatal bacteraemia. 
In the antibiotic era little attention has been paid to 
haeaolytic streptococcal bacteraemia. A few reports have 
s~ggested that thig has a high mortality; underlying aalignancy 
is a predigpoging factor; and infection usually arises from the 
14 
skin or subcutaneous tissues. In this group ( alt.hough the 
numbers are small) diabetes and underlying cancer appeared to be 
predisposing factors. The skin was the most c~IIUllon primary site 
but was undetermined in 4 cases. Any of the major complications 
of bact.eraemia wer.e serious harbingers of death and interestingly 
2 patients developed endocardit.is. Most deaths were due to the 
bacteraemia and only one due to the underlying malignancy. 
6) S. AUREUS. 
RESULTS. The clinical features of S. aureus bacteraemia are shown 
on Table 7. 
TABLE 7. CLINICAL FEATURES OF s. AUREUS BACTERAEMIA. 
EPISODES 7. DEATH 7. 
.. I1BER 29 12 12 41 
SEX 
Hale 22 76 7 32 
Female 7 24 5 71 
SITE 
Respiratory 6 21 5 83 
Undetermined 9 31 4 44 
Skin 5 17 0 0 
o ne/Joint 2 7 0 0 
Cardiac 3 10 1 ; 33 · 
Urinary tract 2 7 1 so · 
i.!.NT 2 7 1 50 
UNDERLYING DISEASE 
Nil 4 14 
Diabetes 2 7 
Rheumat oid arthritis 2 7 
COMPLICATIONS 
Acute renal failure 6 21 5 83 
Respiratory failure 2 7 2 100 
Hepatic dysfunction 1 4 
Cerebral embolus 2 7 2 100 
Shock 1 4 1 100 
CAUSE OF DEATH 
Bacteraemia 6 21 
Cerebral embolus 2 7 
Miscellaneous 4 14 
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DISCUSSION. s. aureus is a ubiquitous skin parasite in man 
causing skin and subcutaneous infection. It occasionally causes 
serious infection in joints, bones, lungs and on heart valves 
often with high morbidity and aortality. Staphylococcal 
bacteraemia is rising in incidence but aost of this is related to 
no~ocoaial sepsis. Nonetheless comaunity acquired bacteraemia is 
still an important problem. Males outnuaber females by 2 to 1 and 
confusion is an important presenting syaptom in 30 - 407.. Fifteen 
to thirty percent of cases are associated with osteitis and 
shock is rare. Primary pneumonia usually occurs post influenza 
and has an poor prognosis with a aortality of up to 507. in 
20 
adults. 
Jn the survey group there were 29 cases with a mortality of 
417. which is slightly higher than the expected mortality of 307.. 
The male to female preponderance reported by others was 
confirmed. The primary site of infection was quite varied and not 
unexpected although in 9 this was undetermined. Primary osteitis 
however had a very low incidence probably due to the exclusion of 
paediatric patients. Although the nuabers are saall priaary S. 
aureus pneumonia associated with bacteraemia had a 837. death rate 
(considerably higher than the usually quoted aortality> which 
contrasts with the absence of death if the primary site of 
infection was the skin. This is somewhat similar to the 
difference in mortality between Klebsiella pneuaoniae and urinary 
tract infection. The reason for this high aortality in the 
former group was unclear as all cases were recognised clinically 
and appropriate anti-staphylococcal antibiotics were prescribed 
16 
usually intravenous cloxacillin alone. 
Diabetes mellitus is usually considered a predisposing factor 
for the development of S. aureus infection but in this series it 
was only seen in 7% which is considerably lower than for all 
bacteraemic patients. Despite the high mortality for the group 
shock occurred in only 1 patient which confirms previous 
observations. Other complications like ARF and respiratory 
failure were more common and ominous markers of death in 
contrast. Interestingly bacteraemia was the direct cause of death 
in only 50% and cerebral embolus was an iaportant factor in 2 
patients with endocarditis. 
unknown. 
Cn 3 cases the cause of death was 
SOURCE OF INFECTION 
DEFINITION 
The source of bacteraemia was defined as clinically known if 
there was an obvious source of infection or the saae organisa was 
isolated from the blood and the local site of infection. 
RESULTS 
The respiratory and urinary tracts were the most co .. on 
primary siteR of infection but in 19.2% it was unknown. (Table 
8). The mortality of priaary pneumonia with bacteraemia was 
significantly higher <p<0.005) than the rest of the group 
contrasting with the significantly lower mortality for urinary 
tract infection (p<0.04). Only 1 patient out 13 died if the 
source of intection was the genital tract (in aoBt cases due to a 
spontaneous septic abortion> 
significant. 
but this was not statistically 
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TABLE 8 MORTALITY RELATED TO SOURCE OF INFECTION 
SOURCE EPISODES 7. MORTALITY 7. . 
Respiratory system 64 26.8 28 44 p<0,005 
Urinary tract 58 24.2 10 17 p<0,04 
Unknown 46 19.2 17 31 
Skin 16 7 5 31.2 
Genital tract 13 5.4 1 7.7 
Gastro-intestinal 13 5.4 4 31 
tract. 
Cardiovascular system 13 5.4 2 15.5 
Biliary t.ract. 8 3.3 1 13 
Miscellaneous 8 3.3 2 25 
TOTAL 239 100 70 29.2 
DISCUSSION 
The marked difference in mortality between the 2 most common 
sources of bacteraemia i.e. the respiratory and urinary tracts 
was probably due to the extremely high mortality for primary S. 
aureus and Klebsiella pneumonia and the low mortalJty for E. coli 
infection which is the most common cause of urinary tract 
infection (46/58 cases}. Inherent differences between the urinary 
and respiratory tract may also have a role if one looks at 
differences in outcome int.he Klebsiella group. 
There was a low mortality related to underlying endocarditig 
1 
which also has been observed by Ispahani. The genital tract also 
had a low · mortality and this was probably due to the a 
combination of early aggressive combination antibiotic therapy, 
surgical evacuation of the septic products of conception (as most 




Treatment was considered appropriate if the infecting organism 
was susceptible to standard in vitro testing and was recommended 
by standard clinical practice guides. Antimicrobial treatment 
was considered inappro~riate if the organism was resistant· to in 
vitro testing and the treatment regimen was inferior to 
recommended standard practice. Prompt treatment was defined as 
an appropriate antimicrobial given within 12 hours of admission 
and delayed if given after this period. 
RESULTS 
In 7 patients (2.97.} no antimicrobial therapy was prescribed 
and 6 of these patients died (85.77.) (Table 9}. In a further 9, 
!~appropriate antibiotics were prescribed with a 88.87. mortality. 
Eighteen patients had delayed but appropriate treatment with a 
55.57. mortality. Comparing this outcome to those patients with 
those receiving prompt antimicrobial therapy there was a highly· 
significant difference in outcome (p<0,000001}. 
Table 10 refers to in vitro resistance to commonly used 
antibiotics. E. coli and Klebsiella had a high resistance to 
ampicillin (59.77. and 94.7 respectively) and to a .lesser extent 
cotrimoxazole · (37.57. and 44.47. respectively). s. aureus was 
generally resistant to penicillin but a significant proportion 
{21.87.) were methicilin resistant. All strains of S. pneumoniae 
were .sensitive to penicillin. 
27 Patients received oral antibiotics prior to admission. 
There were 5 deaths (18.57. N.S.> 
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TABLE 9 MORTALITY RELATED TO ANTIMICROBIAL TREATMENT 
TREATMENT NUMBER 7. MORTALITY 7. 
Nil 7 2.9 6 85.7 
Inappro- 9 3.7 8 88.8 p<0,000001 
priat.e 
55.5 Delayed 18 7.5 10 
Prompt. 205 85.8 46 22.3 
TABLE 10 ORGANISM RESISTANCE TO STANDARD IN VITRO TESTING 
E.coli Klebsiella S. aureus S. pneumoniae 
7. 7. 7. 7. 
Penicillin 81.2 0 
Ampicillin 59.7 94.4 0 
Cot.rimoxazole 37.5 44.4 
Cloxaci llin 21.8 
Cefot.axim.e 0 0 
Aaikacin 0 0 
DISCUSSION 
Init.iat.ion of early appropriate anti-microbial therapy was an 
import.ant. factor in out.come which has been observed in other 
1, 3, 10 
series on bact.eraemia Only 2 out. of 18 patients survived 
if no or inappropriate ant.i-microbials were administered. 
Furthermore · over 507. of patients died who had delayed but 
appropriate treatment. Taking t.hese fact.ors together t.his had a 
highly significant bearing on outcome Cp<0,000001) and for t.his 
reason antibiotics should be administered promptly after taking 
appropriate blood cultures in patients with suspected 
bacteraemia. The choice of antibiotics should be judged by local 
sensitivities of organisms . In our. study the overwhelming 
20 
majority of gram negative organisms were sensitive to Cefotaxiae 
or an a-inoglycoside and the majority .of non-staphylococcal graa 
positive organisms were sensitive to Pencillin or Cefotaxiae. It 
would therefore seea appropriate that initial treatment should 
consist of either Cefotaxiae (or ~iailar third generation 
cephalosporin) alone or a coabination of Penicillin and 
aainoglycoside until appropriate sensitivities are available. 
The only weakness of this regiaen would be the liaited 
staphylococcal cover and if this organisa is suspected a specific 
anti staphylococcal agent should be added. One perturbing factor 
is the 21.87. cloxacillin resistance which aay influence selection 
of an anti-staphylococcal agent.Resistance to cotriaoxazole and 
particularly aapicillin was very high aaongst graa negative 




Symptoas prior to admigsion were recorded with special reference 
to fever, rigors, sweats, confusion, vomiting and diarrhoea. The 
adaission teaperature, total leucocyte count, platelets,liver and 
renal function, pulse and blood pressure were recorded. 
Underlying disease was categorised as rapidly fatal Ce.g.adults 
with acute leukaeaia or blastic relapse of chronic leukaemia), 
ultillllStely fatal (disease likely to be fatal in 5 years), non 
to be fatal in 5 years>, and none fatal {disease unlikely 
4,5,20 
(previously fit). A patient was considered to be alcoholic 
if this was stated in the case records. 
21 
1 ) . SYMPTOMS 
RESULTS 
Patients symptoms are recorded in Table ti.Forty seven 
patients reported none of these syaptoas and only 18 (7. 51.) 
fever,rigors and sweats. Confusion only was noted in 26 and this 
was associated with a 581. aortality (p=<0,002). 

































Interestingly classical syaptoas of bacteraeaia were not 
reported with a very high frequency. Fever occurred in only 43% 
and the combination of fever,rigors and sweating in 7.5:r.. 
Clinicians should be therefore alerted to unusual presentations 
of bacteraeaJa. This is well borne out in the patients who 
presented with confusion alone. In this group there was a 
significantly higher mortality. ( 581., p<0.002) In over 501. this 
was related to a failure to recognise bacteraeaia by .the 
attending physician resulting in a delay or failure to institute 
antimicrobial therapy. This aay represent only the tip of the 
iceberg as the performance of a blood culture suggests that 
bacteraemia was con~idered as a possible diagnosis but not 
~ated because of a low index of suspicion. ln the majority of 
22 
cases this was in the >65 age group. It is possible that patients 
are dying without blood cultures being performed particularly in 
26 
elderly persons. Gleckman also stressed this point that in 
elderly patient~ with a change in mental status who may not be 
febrile bacteraemia should always be considered as a possible 
diagnosis. 
2)FEV~R, PULSE AND BLOOD PR~SSURE. 
RESULTS 
The highest temperature in the first 24 hours after adaission 
was recorded in 228 patients {Figure 2) with a aean of 38.4 C 
(range 33 - 41.2). Failure to mount an adequate febrile response 
(temperature> 37 C) occurred in 24 patients with a 54X mortality 
{p=0,01). One hundred and twenty eight had a fever> 38.5 with a 














I mortality total 
<37°C . 372.3a.s0 c >38.5°C 
TEMPERATURE 
FIG . 2. The highest initial temperature in relation to mortality . 
This study also confirmed the oft.en noted fact. that. patients 
with bact.eraeaia do not. necessarily mount. a febrile response in 
the first. 24 hours aft.er admission and this was ·associated with 
1,12 
a significantly poorer out.come (p=0,01). 
3) UNDERLYING DlS~ASE 
RESULTS (Table 12 and 13) 
Sixty one patients were previously fit. with a aort.alit.y of 
237. <N.S). Over 507. were categorised as non fatal disease with a 
aortalit.y of 277. CN.S). There were 38 patients with ultimately 
fat.al disease wlt.h a significantly higher aort.ality <p~0,04). 
The nutabers in the rapidly fatal group were too saall for 
analysi~.The most prevalent. underlying diseases are shown in 
Table 7. There was no significant. differences in aortalit.y. 
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TABLE 12 MORTALITY RELATED TO UNDERLYING DISEASE CATEGORY 
DISEASE CATEGORY NUMBER Y. DEATHS Y. 
Rapidly fatal 5 2. 1 2 40 
Ultimately fatal 38 15.9 17 45 P=0,04 
Non fatal 135 56.4 37 27 
None 61 25.6 14 23 
TABLE 13 MORTALITY RELATED TO MAJOR UNDERLYING DISEASE 
UNDERLYING DISEASE NUMBER Y. DEATHS Y. 
Diabetes mellitus 57 23.5 21 37 
Alcoholisa 51 21. 3 20 39 
Iaaunosuppression 29 12. 1 9 31 
Nil 61 25.1 14 23.3 
DISCUSSION 
The underlying pre-existing disease had a small but 
significant factor in influencing outcome. Not unexpectedly a 
worse outcoae was seen in patients with ultimately fatal disease. 
Patients without underlying disease did not fare significantly 
better. 
(23,57.} 
There was a high incidence of diabetics in the series 
which has not been described in previous studies of 
bacteraemia although it is not surprising that it should occur 
due to diabetics susceptibility to infection. Diabetics had a 
slightly worse outcome but not significantly so. Other major 
underlying dineases were alcoholisa in 51 and iaaunosuppressive 
treatment in 29 but these patients did not do significantly 
worse. 
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4) LEUCOCYTES AND PLATELETS 
RESULTS 
The mean leucocyte and platelet counts were 14,500p/l <range 
400 7500) and platelets 220,000p/l(range 900 - 721,000) 
respectively (Table 14 & 15). There was significant increase in 
mortality if the leucocyte count was below 2,500p/l Cp=0,01) and 
the platelet count below 100,000p/l Cp=0,002>. The clinical 
features of patients with severe leukopaenia not on prior 
treatment with cytotoxics or iamunosuppressive agents are shown 
in Table 16. 
TABLE 14 OUTCOME RELATED TO THE TOTAL PERIPHERAL 
LEUKOCYTE COUNT 
CELL COUNT Cp/L) NUMBER DEATHS 7. 
<2-,SOO 15 9 60 p=0.01 
2~500 - 9,999 63 19 30 
10,000 - 20,000 94 23 25 
> 20,000 43 12 28 
Mean count 11,500 (range 400 75,000) 
TABLE 15 OUTCOME RELATED TO TOTAL PERIPHERAL PLATELET COUNT 
CELL COUNT <p/L) NUMBER DEATHS 7. 
(100,000 36 19 53 p<0.002 
>100,000 176 43 23 
Mean count 220,000 (range 9,000 - 721,000 ) 
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TABLE 16. CLINCAL FEATURES OF PATIENTS WITH LEUKOPAENIA NOT 







































































Initial laboratory data was obtained in the aaJority of patients. 
The presence of leukopaenia <WCC (2,500) which incidentally was 
usually due to bacteraeaia and not iaaunosuppressive or cytotoxic 
agents and a throm.bocytopaenia (100,000 u/1 were significantly 
associated with a poor outcome. The cause of such of severe 
leukopaenia in bacteraemia is not well established. It aay be due 
to peripheral consuaption e.g. a severe lobar pneuaonia, as part 
of a disseminated intravascular coagulopathy, due to an 
underlying disease process e.g. hypersplenJ.sa or due to cytotoxic 
drug therapy. In analysing the clinical features of patients with 
severe leukopaenia not on immunosuppressives these features are 
borne out. to some extent. Pneumonia was common but not. 
disseminated int.ravascular coagulation. Interestingly the most 
common organism was Klebsiella but the reasons for this are not 
entirely clear. 
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5) LIVER FUNCTION 
DEFINITIONS 
Liver function tests were analysed on admission. Patients 
with biliary sepsis were excluded from analysis and the remainder 
were divided into patients with Ci) no underlying liver disease 
or alcoholism, (ii) prexisting liver disease and no alcoholism, 
(iii) alcoholism. 
> 20 umol /1. 
RESULTS 
Jaundice was defined as a conjugated bilirubin 
Admission liver functions are shown in Table 17. Comparing the 
alcoholic and non alcoholic group the serum albumen, as part ate 
and alanine transaminases < · AST and ALT respectively) were 
similar but the alcoholic group had higher levels of bilirubin 
and gamma-glutamyl transferase (GGT> and lower levels of 
alkaline phosphatase. Patients in group (ii) numbered only 1 and 
were too small to analyse. 
Fifteen patients without underlying liver disease or 
alcoholism (Table 18) were jaundiced on admission. There were 10 




( 1) , 
E. 
s. 
coli (5), Klebsiella ( 1) , haemolytic 
aureus (1) and Salmonella typhi ( 1). 
Complications included acute renal failure (4) , respiratory 
failure (5) , shock ( 4) ' and disseminated intravascular 
coagulopathy (2). Mortality was 407.(6/15 N.S.) and most deaths 
were due to overwhelming bacteraemia. The mean transaminases, 
alkaline phoshatase and bilirubin were elevated 2-3 times the 
upper limit of normal and the GGT 5 times (figure 3). 
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TABLE 17 LIVER FUNCTION OF PATIENTS ON ADMISSION WITHOUT BILIARY 
TRACT SEPSIS 






































( 14 - 45) 
48 
(3 - 330) 
51 
( 1 - 530) 
99 
( 1 - 897) 
155 
< 16 - 638) 
25 
(2 - 298) 
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44 23 
( 0 - 113) 

















(15 - 45) 
43 
(3 - 330) 
49 
( 1 - 375) 
77 
(1 - 605) 
161 
(16 - 638) 
18 
(2 - 218) 
7 
(0 - 80) 
TABLE 18 LIVER FUNCTION TESTS OF JAUNDICED PATIENTS WITHOUT 
ALCOHOLISM,LIVER DISEASE OR BILIARY SEPSIS. 
NUMBER MEAN RANGE 
Bilirubin (umol/1) 15 59 36 118 
Conj.bilirubin 15 37 21 80 





(u/1) 14 119 25 330 
(u/1 > 14 116 22 335 
(u/1) 14 244 34 605 
Phos (units) 15 284 78 638 
DISCUSSION 
An interesting aspect of the study was the documentation of 
liver function in the majority of patients excluding those with 
underlying biliary sepsis. Not surprisingly the alcoholic 
patients had a marked elevation in the mean gamma glut.amyl 
transferase with a lesser elevation of alkaline phosphatase and 
bilirubin. The group without liver disease or alcoholism 
interestingly had a greater elevation of alkaline phosphatase 
but the mean gamma glut.amyl transferase was Just outside the 
normal range and significantly lower than the alcoholic group. 
Fifteen patients had jaundice on admission without a 
satisfactory explanation except on the basis of bacteraemia(Table 
10). This complication has been the subject of several reports 
27-33 
and the incidence has ranged from 0,6% to 34%. The causes of 
the jaundice are unknown but is probably related to endotoxin or 
34 
other bacterial toxins. The jaundice has been reported to be 
35 
cholestatic in nature and Hoof nag le in pooling data from 7 
series showed a picture of hyperbilirubinaemia often marked with 
27,30 
marginal elevation in the liver enzymes. Liver histology has 
shown intrahepatic cholestasis with minimal or no hepatocyte 
30 
27 
necrosis. Miller suggested that this picture was due to a 
selective defect in excretion of bilirubin rather than 
intrahepatic cholestasis. All these studies are flawed by 
problems in patient selection and definition of Jaundice. 
This survey probably represents the only one that has 
documented liver function in patients with bacteraemia in a 
prospective manner. The incidence of jaundice on admission was 
7.87. and there was no significant increase in mortality. In 
contrast to others the mean levels of transaminases and alkaline 
phoshatase were elevated in proportion to serum bilirubin but the 
gamma-glutamyl transferase showed a ·greater rise (Figure 3). This 
suggests a more hepatocellular cause for the jaundice which is 
not changed by the exclusion of the patient with typhoid Ca known 
cause for ·reactive hepatitis). It is however interesting to note 
that 3 patients demonstrated the finding of disproportionate rise 
in bilirubin compared to liver enzymes. This suggests that the 
pattern of jaundice occurring in bacteraemia is variable and may 
have a multifactorial aetiology. 
COftPLICATIONS 
1> OVERALL 
RESULTS. The major complications of bacteraemia are listed in 
Table 19. 
31 
TABLE 19 OUTCOME RELATED TO COMPLICATIONS OF BACTERAEMIA. 
COMPLICATIONS EPISODES 'l. MORTALITY 'l. 
None 109 46 11 10 p<0.000001 
Acute Renal failure · 58 24 31 53 p<0,001 
Respiratory failure 39 16 26 67 p<0,000001 
Shock 36 15 24 67 p<0,000001 
Liver dysfunction 25 10 6 24 
D. I. C 16 7 9 56 p<0,02 
Endocardit.is 7 3 4 57 
DISCUSSION. It is not. surprising that the aajor complications of 
bacteraeaia particularly acute renal failure, shock and 
respiratory failure are highly significantly associated with a 
poor noutcoae. Further discussion will focus on the latter 
coaplications particularly acute renal failure. 
2) ACUTE RENAL FAILUHE 
DEFINITIONS 
ARF was defined as a doubling or more in serua creatinine froa 
baseline. These patients were further subdivided into those who 
had recovery of renal function in the first 24 hours after 
adaission determined by a progressive fall in serum creatinine 
without dialysis and those who had persistent elevation or a 
rising serum creatinine and/ or required dialysis. These 2 
groups were labelled Group 1 and 2 respectively. 
RESULTS 
During the 1 year study period 239 cases of coaaunity acquired 
bacteraeaia were identified of which 58 (241.) had ARF. 
PATIENTS 
Of the 58 cases 30 occured in male and 28 in feaale patients. 
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The mean age was 54 years (range 17 - 85).The overall mortality 
was 537. (31 patients) compared with 227. for bacteraemic patients 
without ARF (p<0,001).0lder patients <>65 years) 
signific·antly worse outcome (797. versus 457., p<O, 05). 




The distribution of organisms and associated mortality for ARF 
and bacteraemic patients without ARF is shown in Table 20. There 
was a greater number of gram negative than gram positive 
organisms in the ARF group (537. versus 387.) compared with 
bacteraemic patients without ARF. The mortality due to gram 
positive organisms in the ARF group was significantly higher than 
graa negatives (737. versus 427., p<0,05). The relative incidences 
of the most common organisms i.e. E.coli, Klebsiella sp.,S 
pneumoniae, S aureus, and p Haemolytic streptococci were very 
similar in each group. Infection due to E~ coli had a 
significantly better outcome (p=0,01) in the ARF group but S. 
aureus and B haemolytic streptococci had an almost uniformly 
fatal outcome. 
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TABLE 20. INFECTING ORGANISMS AND MORTALITY. 
ORGANISM NO RENAL FAILURE ACUTE RENAL FAILURE 
EPISODES 1. DEATHS 1. EPISODES~ DEATHS 7. 
GRAM NEGATIVE 
E. col i 51 28 8 16 18 31 5 28 
Klebsiella sp. 10 6 6 60 8 14 5 63 
Salmonella typhi 4 2 0 0 0 0 0 0 
N. meningitides 4 2 0 · O 0 0 0 0 
Miscellaneous 8 4 2 25 5 9 3 60 
TOTAL 77 43 16 21 31 53 13 42 
GRAM POSITIVE 
s. pneumoniae 39 17 10 33 12 21 7 58 
s. aureus 23 13 7 30 6 10 5 83 
B Haemolytic 7 4 4 57 4 7 4 100 
Streptococci(A,B,C) 
s . aitior 11 5 0 0 0 0 0 0 
Miscellaneous 19 16 2 11 0 0 0 0 
TOTAL 99 55 23 23 22 38 16 73 
POLY'MICROBIAL 5 2 0 0 5 9 2 40 
GRAND TOTAL 181 100 39 22 58 100 3.1 53 
SOURCE 
The most common sources of infection were very similar to 
bacteraemic p~tients wihout ARF i.e. the respiratory and urinary 
tract and undetermined sources. In addition the trend to a 
higher mortality for respiratory infection and lower for urinary 
infection was confirmed. Undetermined sources formed an important 
subgroup.Other sources of infection are listed in Table 21. 
,, 
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TABLE 21. MORTALITY RELATED TO SOURCE OF INFECTION. 
NO RENAL FAILURE ACUTE RENAL FAILURE 
EPISODES 7. DEATHS 7. EPISODES 7. DEATHS 7. 
SOURCE 
Re.spirat.ory 49 27 18 37 15 26 10 67 
Urinary t.ract. 40 22 4 15 18 31 6 33 
Undetermined 31 17 9 29 15 26 8 53 
Skin 12 7 3 25 4 7 2 50 
Genital t.ract. 12 7 0 0 1 2 1 100 
Gast.ro-int.est.inal 10 6 2 20 3 5 2 67 
tract. 
Cardiovascular 13 5 2 16 0 0 0 0 
Biliary 7 4 0 0 1 2 1 100 
lllfiscellaneous 7 4 1 14 1 2 1 100 
TOTAL 181 100 39 22 58 100 31 53 
I . 
ANTil1ICROBIAL THERAPY 
The failure to adainist.er appropriate antimicrobials ' or a 
delay in their use in all bacteraemic pat.ient.s was associated 
with a high mort.alit.y. This trend was confirmed int.he ARF group 
with all 9 of these patients dying from bacteraemia or 
complications thereof (p<0,0005). 
CLINICAL VARIABLES 
The mean temperature, plasma creat.inine, white cell count. 
<WCC) and platelets for the study were 37.9~ (range 33 41,2), 
368 umol/1 (91 - 1470}, 15,900 pl <0,7 - 65,000} and 177,000 pl 
<9 - 605,000> respectively. The mean WCC, serum creat.inine and 
platelet. count.s fort.he 2 subgroups are listed int.able 22. The 
most important. pre-existing disease was diabetes mellitus 
occuring in 35_7. of the ARF group compared vi th 207. for 
bacteraemic patients without. ARF (p<0,05). Ten pat.ient.s had no 
underlying disease. Diabetics did not kave a significantly worse 
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outcome. Nine patients had severe ARF i.e. an initial serum 
creatinine >500umol/l and only 4 died. 16 patients were admitted 
to the intensive care unit (of whom 11 were ventilated) and only 
4 survived (p<0,04). 
TABLE 22. COMPARISON BETWEEN GROUP 1 AND GROUP 2 PATIENTS. 
GROUP 1 GROUP 2 
NUMBER 30 28 
AGE(mean) 50 57 
MORTALITY 6(207.) 25(897.) p<0,000001 
CREATININE<mean) 385 351 
W. C. C. (mean) ul 17,9 13,7 
PLATELETS<meanl ul 185 168 
TYPE OF ORGANISM 
E. coli 13 5 NS 
Klebsiella 3 5 
H. streptococci 0 4 
s. aureus 2 4 
.COMPLICATIONS 
Shock 9 13 NS 
Resp. failure 6 12 NS 
PRIMARY SITE 
Resp. tract 5 10 NS 
Urinary tract 11 7 NS 
CAUSE OF DEATH 
Bacteraemia 5 20 
Nosocomial sepsis 0 2 
Miscellaneous 1 3 
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COl1PLICATl0NS 
The most frequent complications of bacteraeaia associated with 
ARF were shock, respiratory failure, disseainated intravascular 
coagulopathy, and hepatic dysfunction occurring in 22, 18, 10 and 
11 pati.ents. (Table 23) Shock and respiratory failure were 
associated with a statistical significant increase in aortality 
to 737. and 787. (p<0.02 and p<0.002 respectively). 
TABLE 23. CONDITIONS COMPLICATING BACTERAEMIA AND ARF. 
COMPLICATIONS EPISODES DEATHS 7. 
Resp. failure 18 14 78 p<0,002 
Shock 22 16 73 p(0,02 
D. I.e. 10 5 50 
Hepatic dysfunction 11 5 45 
RESOLUTION OF ARF 
In group 1 where early recovery of renal function occurred there 
were 30 patients with a 207. mortality. In contrast in group 2 
where there was failure of initial recovery or a requirement for 
dialysis there were 28 patients with a 897. mortality 
< p<O, 000001> . Nine of thege patients were dialysed and only 2 
survived. No patient died of factors attributable directly to 
renal failure, hyperkalaeaia, metabolic acidosis, and/or volume 
overload. Most of these patients died before dialysis was 
indicated. The overall characteristics of the 2 groups are listed 
ln table 22 and serial renal function is shown in figures 4 and 5. 
Group 2 tends to have more markers of adverse outcome such as 
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The prevalence and outcome of ARF due to bacteraemia is not 
36-41 
well defined. In this survey the prevalence of ARF was 247. 
and was shown to be a significant marker of high mortality in 
bacteraemia despite the inclusion of patients with mild ARF by 
all criteria. Early resolution of ARF (group 1 patients) with 
treatment of the underlying bacteraemia was associated with a 207. 
mortality which is lower than the overall mortality for all 
bacteraemic patients (297.). In contrast group 2 patients had a 
highly significantly . worse outcome with a mortality of 897. 
<p<O, 000001>. The reason for this marked diference is not well 
explained. Although group 2 had more markers for adverse outcome 
of bacteraemia no factor reached any statistical or clinical 
significance. Another noteworthy point is the small role for 
dialysis in this survey. In all, only 9 patients were dialysed 
out of a total of 58 and only 2 of these patients survived C<57. 
of the total) but it is unknown if the early institution of 
dialysis would have improved survival. 
The mortality was not influenced by race or sex but those over 
the age of 65 had a significantly worse outcome which has been 
37,38 39,42 
noted by some but not all Diabetes mellitus was 
found to predispose to the development of ARF. 
A greater number of patients had gram negative bacteraemia in 
the ARF group compared with bacteraemic patients without ARF but 
of particular interest was the high mortality of gram positive 
(73%) 
ARF. 
compared to gram negative (42Xi p<0,05) bacteraemia and 
This was due to a 90'l. mortality for B haemolytic 
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streptococcal and S. aureus bacteraemia. 
Another important finding of the study is the 1007. mortality 
associated with the delay or use of inappropriate antimicrobials 
in patients with ARF. In over half of these instances the delay 
was due to a failure to suspect bacteraemia as a cause for the 
\ 
ARF. The importance of early, aggressive and appropriate 
antimicrobial therapy is stressed and it should be commenced as 
soon as suitable cultures have been obtained. 
Not surprisingly the presence of any of the other major 
complications of bacteraemia i.e. shock and respiratory failure 
was associated with a high mortality. Interestingly patients with 
severe acute renal failure ( plasma creatinine concentrati,on 
)500 umol/1 } did not do any worse than the other patients. 
2> RESPIRATORY FAILURE 
DEFINITIONS. 
Respiratory failure was defined for ~he purposes of the study 




The clinical characteristics of patients with respiratory 
failure are shown in Table 24. The cause of the respiratory 
failure was not recorded but in most instances it was probably 
due to the adult respiratory distress syndrome. Four patients 
died of respiratory failure without being ventilated. 
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TABLE 24. CLINICAL FEATURES OF PATIENTS WITH RESPIRATORY 
FAILURE. 
EPISODES 7. DEATHS 7. 
NUMBER 39 16 26 67 
SEX 
!1ales 28 72 18 64 
Females 11 28 8 73 
ORGANISMS 
Graa negat.ive 12 31 11 91 
Gr am posit.ive 24 62 14 58 p<0.05 
Kl e b.siella 11 28 7 64 
S.aureus 3 8 3 100 
s. pneumoniae 7 18 6 86 
E. coli 6 15 3 50 
Miscel l aneous 12 31 7 58 
PRIMARY SITE 
s p i ratory 19 49 15 79 
Ot.her 20 51 11 55 p<0.002 
ALCOHOLISM 14 36 10 71 
· coMPLICATIONS 
Acut.e renal failure 17 44 13 76 
Shock 19 49 17 90 p<0.04 
D.I.Coagulopat.hy 6 15 4 67 
DISCUSSION. 
Respirat.ory failure is a well recognised complicat.ion of 
bacteraemia particularly gram negative endotoxaemia. This 
complication has not been well documented in previous studies of 
bacteraemia. In this survey the prevalence was 167. with a 
sig'n ificantly increased mortality of 677. compared to patients 
without respiratory failure. These results approximate those 
43 
obt.ained by Kaplan who studied patients with gram negative 
bacteraemia. The mortality in that study was probably higher due 
to inclusion of patients with nosocomial sepsis. 
Interesting points to arise from the data are : 1> The 
preponderance of patients with Klebsiella infection; 2) The very 
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high mortality if the primary site of infection was the lungs 
compared to other sites (797. versus 557., p<0.002); Gram positive 
bacteraeaia was almost uniformly fatal compared to graa negative 
(927. versus 587., p<0.05). The reasons for this is unclear but 
certainly the trend of the study is for Klebsiella infection to 
be associated with serious complications and the very high 
mortality for gram positive bacteraemia to have an ominous 
prognosis if coaplicated by renal failure, 
or ~hock. 
respiratory failure 
One perturbing point was the 4 deaths due to respiratory 
failure which occurred without the institution of ventilatory 
support. The reason for this appeared to be a failure to 
recognise clinically that the patient was severely hypoxaemic, 




Shock was defined as a systolic blood pressure of< 90aaffg in 
a clinically euvolaemic patient. 
RESULTS. 




TABLE 25. CLINICAL FEATURES OF PATIENT WITH SHOCK. 
EPISODES 7. DEATHS · 7. 
NUMBER 36 15 26 72 
SEX 
l'la les 20 56 16 80 
aales 16 44 10 63 
RGANISHS 
Graa positive 13 36 12 92 
Gram negative 21 58 13 62 
Klebsiella 8 22 7 88 
S.aureus 2 6 2 100 
s. pneumoniae 8 22 7 88 
E. coli 7 19 2 29 
iscellaneous 11 31 8 73 
PRIMARY SITE 
R s piratory 13 36 13 100 p(0.002 
Other · 23 64 13 57 
ALCOHOLISM 6 17 5 83 
COMPLICATIONS 
Acut.e renal failure 22 61 16 73 
espiratory failure 18 50 15 83 
D.I.Coagulopathy 6 17 3 50 
DISCUSSION. 
Shock is a well recognised complication of bacteraemia 
particularly gram negative endotoxaemia. In this survey the 
prevalence was 157. and was associated with a significantly 
increased mortality. (727.) Gram negative organisms predominated 
but. mortality for gram positive bact.eraemia with shock was much 
higher (·927. versus 627.) alt.hough t.he numbers are small to make 
definitive conclusions. Patients wit.h pneumonia and shock had a 
significantly increased mortality compared with those who had a 
other primary sites of infection (1007. versus 577., p<0.002). 
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FACTORS IN DEATH 
RESULTS 
The iaajority of deaths were directly related to the original 
bacteraemia (Table 26) and a much smaller number due to 
nosocomial sepsis and the underlying disease process. Secondary 
complications directly or indirectly related to the underlying 
bacteraeaia accounted for a further 17 deathn. These included 
massive pulaonary embolus (2) ,respiratory failure ( 4) , 
cerebrovascular accidents (2), mycotic aneurysms (2),endocarditis 
Cl>,sudden death (3),hyperkalaeaia Cl), and unknown (2). 
TABLE 26 FACTORS IN DEATH 
CAUSE OF DEATH NUMBER Y. 
Bacteraeaia 46 66 
Nosocoaial sepsis 4 6 
Underlying disease 3 4 
Secondary or unrelated 17 24 
TOTAL 70 100 
DISCUSSION 
In the majority of patients death was due to the original 
bacteraemia or complications thereof with the underlying disease 
and secondary nosocomial sepsis having ainor roles. It is 
therefore imperative that therapy be directed aggressively and 
appropriately to eradication of the bacteraeaia. Previous data 
presented in this paper suggested that the use of inapproriate or 
no antibiotics was a highly significant factor in deteraining 
outcoae and to improve mortality in comaunity acquired 
bacteraemia proapt and appropriate antibiotics should be 
administered after taking appropriate cultures. For example if 
the 70.51. mortality for the group with delayed, no or 
45 
inappropriate antibiotics was reduced to the overall mortality 
for the study ie 297., 13 patients may have survived and the 
overall death rate reduced to 197.. Other factors that may have 
been prevented were the 4 deaths due to respiratory failure who 
died without the institution of ventilatory support. 
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CONCLUSIONS 
1) Community acquired bacteraemia is a coamon acute aedical 
problem which continues to have a high aortality. 
2) The most common organisms encountered in the study were E. 
coli, S. pneumoniae, and S. aureus. Organisas associated with a 
poor prognosis were B haemolytic streptococci and Klebsiella 
whilst E. coli and Viridans streptococci had a relatively good 
outcome. 
3) The most coaaon sources of infection were the urinary and 
respiratory tracts whilst there were a large number without an 
identifiable priaary site. Outcoae was significantly better if 
the primary source was the urinary tract but worse if it was the 
lungs. 
4) Inappropriate, delayed or no antibiotic therapy was 
significantly associated with an adverse outcome. The coamonest 
reason for inappropriate therapy was the failure to consider 
mental confusion alone as a symptoa of bacteraeaia particularly 
in elderly patients. 
5> E. coli, the commonest gram negative pathogen, was resistant 
to ampicillin and cotriaoxazole in 59.71. and 37.51. of cases 
respectively. 
6) Clinical factors predicting a poor outcoae were confusion; 
failure to mount a febrile response; patients with ultimately 
fatal diseHse; 
re~pectively; 
a WCC < 2,500u/l or platelet count< 100,000 u/1 
and any of the major coaplications of bacteraeaia 
like acute renal failure, respiratory failure, shock and 
disseminated intravascular coagulation. 
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7) The analysis of liver function and jaundice formed an 
important aspect of the study. 
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